Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

NCT01233245 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01233245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01233245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
April 30, 2004
Completion date
June 30, 2009
Enrollment
1,077 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting ms (rrms), secondary progressive ms (spms)